A Study of TmPSMA-02 Chimeric Antigen Receptor (CAR) T-cells in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Clinical trial NCT05489991 · TERMINATED
Trial details
- NCT number
- NCT05489991
- Sponsor
- Tceleron Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-06
- Primary completion
- 2023-05-03
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.